Article
Semaphorin 3fa Controls Ocular Vascularization From the Embryo Through to the Adult.
Investigative ophthalmology & visual science - 1 Feb 2021
Halabi Rami, Watterston Charlene, Hehr Carrie Lynn, Mori-Kreiner Risa, Childs Sarah J, McFarlane Sarah
Abstract excerpt
Purpose: Pathological blood vessel growth in the eye is implicated in several diseases that result in vision loss, including age-related macular degeneration and diabetic retinopathy. The limits of current disease therapies have created the need to identify and characterize new antiangiogenic drugs. Here, we identify the secreted chemorepellent semaphorin-3fa (Sema3fa) as an endogenous anti-angiogenic in the eye....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
